ASH 2023: Exploring Therapeutic Advancements for Chronic Lymphocytic Leukemia - Episode 10
Javier Pinilla, MD, PhD explores evidence on molecular mechanisms leading to resistance in second-generation BTK inhibitors for CLL, providing insights from recently presented data at ASH 2023.